Volume: 43 Issue: Supplementary 1
Year: 2023, Page: 201-204, Doi: https://doi.org/10.51248/.v43i1.2496
Introduction and Aim: More than 85% of cervical cancer (CC) cases are reported in developing countries where access to screening is limited. With localized forms of CC, it is possible to achieve good treatment results using radical procedures compared to locally widespread processes.
Methods: This is a retrospective study of 68 patients with stage IIB CC hospitalized from 2013–2022. During the initial treatment and after a full clinical examination, all patients were diagnosed with stage IIB CC, a parametrial and vaginal involvement.
Results: Forty-six patients (74%) received two courses of chemotherapy, 14 patients (23%) received three courses, and 2 patients (3%) received four courses. The tumor became resectable after two courses in 46 patients, after 3–4 courses all patients moved on to the next surgical stage. Of the early postoperative complications, 9 patients (14.5%) had bladder atony, which was resolved by the conservative method.
Conclusion: Thus, there is a certain category of patients with CC, where it is possible to make the tumor into a resectable form, and this will increase the percentage of the surgical component of treatment, which in turn could increase the 5-year disease-free survival rates of patients with stage IIB CC.
Keywords: Cervical cancer; chemoradiotherapy; neoadjuvant polychemotherapy; 5-year disease-free survival rates; relapse-free survival rates.
1. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., et al., Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249.
2. Chokoev, A., Akhunbaev, S., Kudaibergenova, I., Soodonbekov, E., Kulayev, K., Ospanov, K., et al., Breast Cancer Incidence in Kyrgyzstan: Report of 15 Years of Cancer Registry. Asian Pac J Cancer Prev. 2022;23(5):1603-1610.
3. Bhatla, N., Aoki, D., Sharma, D. N., Sankaranarayanan, R. Cancer of the cervix uteri. Int J Gynecol Obstet. 2018;143(Suppl 2):22-36.
4. Naga, C. P., Gurram, L., Chopra, S. The management of locally. advanced cervical cancer. Curr Opin Oncol. 2018;30(5):323-329.
5. Chargari, C., Peignaux, K., Escande, A., Renard, S., Lafond, C., Petit, A., et al., Radiotherapy of cervical cancer. Cancer Radiother. 2022;26(1-2):298-308.
6. Sobin, L. H., Gospodarowicz, M. K., Wittekind, C. TNM Classification of Malignant Tumours. Chichester, West Sussex; Hoboken: John Wiley & Sons; 2009.
7. Buskwofie, A., David-West, G., Clare, C. A. A Review of Cervical Cancer: Incidence and Disparities. J Natl Med Assoc. 2020;112(2):229-232.
8. Shrestha, A. D., Neupane, D., Vedsted, P., Kallestrup, P. Cervical Cancer Prevalence, Incidence and Mortality in Low- and Middle-Income Countries: A Systematic Review. Asian Pac J Cancer Prev. 2018 Feb 26;19(2):319-324.
Aizhamal Sharshenbaeva, Evgeniya Lim, Altynai Zhumabekova, Ulan Musaev, Abdurakhman Vaninov, Indira Kudaibergenova, Akshay Bhardwaj, Bakyt Toktogaziev. The role of neoadjuvant polychemotherapy in the treatment of patients with stage IIB cervical cancer. Biomedicine: 2023; 43(1) Supplementary issue: 201-204